WuXi PharmaTech’s toxicology facility in Suzhou has received a statement of GLP from the Belgium Scientific Institute of Public Health following two successful GLP inspections conducted by the Belgium GLP Monitorate. The GLP statement acknowledges the capability to carry out toxicology and mutagenicity studies and analytical and clinical chemistry testing with respect to OECD and EC principles of GLP. The inspection included an audit of 16 studies in areas that included general toxicology, gene...